Nexletol is a prescription medication that belongs to the class of cholesterol synthesis inhibitors. Its active ingredient bempedoic acid works by inhibiting the enzyme atp citrate lyase in the liver. This inhibition blocks an early step in cholesterol production which leads to lower levels of low-density lipoprotein cholesterol in the bloodstream. By decreasing hepatic cholesterol synthesis the liver compensates by increasing the expression of ldl receptors that remove cholesterol from circulation. The resulting reduction in circulating ldl particles lowers the risk of cardiovascular events such as heart attack and stroke. Clinically the drug is used to improve glycemic control in patients with type 2 diabetes who also need additional ldl lowering. The net effect of these physiological actions is a modest but clinically meaningful decrease in atherosclerotic plaque formation.

Nexletol is a cholesterol-lowering medication approved for adults with elevated ldl-c. It belongs to a class of drugs known as atp-citrate lyase inhibitors that target cholesterol production. The active component bempedoic acid is converted in the liver to an active metabolite that blocks the enzyme atp-citrate lyase. This inhibition halts the conversion of citrate to acetyl-coa, reducing the synthesis of cholesterol. As cholesterol production falls the liver compensates by increasing ldl-receptor expression on its surface. Additional receptors enhance the clearance of ldl particles from the bloodstream, leading to measurable declines in ldl-c concentrations. Clinical trials demonstrated that Nexletol lowers ldl-c by roughly fifteen to twenty percent when administered as monotherapy or with a statin. Therapy is generally continued long term to maintain the achieved reduction in ldl-c.

Nexletol is a cholesterol reduction medication that works by inhibiting a specific enzyme in the liver. Common side effects may include mild headache and abdominal discomfort. Some patients report elevated liver enzymes, which are monitored through routine blood tests. Rare but serious adverse reactions can involve muscle pain or weakness, requiring medical evaluation. The medication may interact with certain other drugs, altering their effectiveness. Overall the safety profile is considered favorable when used as directed.

Nexletol may cause mild headache in some patients. It can also lead to upper respiratory infections such as colds. Some individuals experience nausea or mild stomach discomfort. Less commonly muscle aches or joint pain have been reported. Rarely liver enzyme levels may rise without causing symptoms. Fatigue and dizziness are occasionally observed. Most side effects are temporary and resolve on their own.